Pharming Group N.V.: management transactions · Netherlands · AFM AFM:pharming-group-nv NL NL · AFM Mcap 783M€ Healthcare & Pharma
Browse the full insider trade history of Pharming Group N.V., a listed issuer based in Netherlands. Shares are listed on NL NL, under the oversight of AFM. Operating in the Healthcare & Pharma sector, Pharming Group N.V. has published 116 insider filings. Market capitalisation: €783.2m. The latest transaction was disclosed on 12 March 2026 — Purchase. Among the most active insiders: S. de Vries. Every trade is accessible without an account.
€398,700
4 ops.
Sell Volume
Analyst consensus
4 analysts · 1.90 € Target 2.23 € 2.61 €
Income statement
Revenue 376.1 M€
Gross profit 330.6 M€ 88% margin
Net income 2.9 M€ 3.3% margin
Valuation
PER (trailing) 55.5x
PER (forward) 30.6x
P/Book 3.3x
Beta 0.12
Balance sheet & cash
Market cap 783.2 M€
Total debt 115.8 M€
Free Cash Flow 54.0 M€
Debt / Equity 43%
Profitability & ownership
ROE 5.0%
ROA 4.9%
% insiders 1.9%
% institutions 22.7%
Last declaration on 12 March 2026
Declarations 116 total
Executives ● Purchase9 AFM
02,091,330 shares 0
Restricted share
AFM:189920 · 12 Mar 2026
Ideal exit: 7 Dec 2026 (T+270) Executives ● Mixed9 AFM
0-255,825 shares 0
Restricted share
AFM:187617 · 1 Feb 2026
Executives ● Purchase9 AFM
03,613 shares 0
Gewoon aandeel
AFM:183064 · 6 Nov 2025
Ideal exit: 3 Aug 2026 (T+270) Executives ● Purchase9 AFM
017,550 shares 0
Gewoon aandeel
AFM:176307 · 11 Jun 2025
Ideal exit: 8 Mar 2026 (T+270) Executives ● Purchase9 AFM
041,867 shares 0
Gewoon aandeel
AFM:176241 · 10 Jun 2025
Ideal exit: 7 Mar 2026 (T+270) Executives ● Purchase9 AFM
031,400 shares 0
Gewoon aandeel
AFM:176244 · 10 Jun 2025
Ideal exit: 7 Mar 2026 (T+270) Executives ● Purchase9 AFM
031,400 shares 0
Gewoon aandeel
AFM:176242 · 10 Jun 2025
Ideal exit: 7 Mar 2026 (T+270) Executives ● Purchase9 AFM
031,400 shares 0
Gewoon aandeel
AFM:176243 · 10 Jun 2025
Ideal exit: 7 Mar 2026 (T+270) Executives ● Purchase9 AFM
031,400 shares 0
Gewoon aandeel
AFM:176245 · 10 Jun 2025
Ideal exit: 7 Mar 2026 (T+270) Executives ● Purchase9 AFM
03,614,572 shares 0
Restricted share
AFM:171687 · 12 Mar 2025
Ideal exit: 7 Dec 2025 (T+270) Executives ● Purchase9 AFM
01,023,302 shares 0
Restricted share
AFM:171449 · 7 Mar 2025
Ideal exit: 2 Dec 2025 (T+270) Executives ● Purchase9 AFM
011,316 shares 0
Gewoon aandeel
AFM:165345 · 31 Oct 2024
Ideal exit: 28 Jul 2025 (T+270) Executives ● Purchase9 AFM
08,487 shares 0
Gewoon aandeel
AFM:165346 · 31 Oct 2024
Ideal exit: 28 Jul 2025 (T+270) Executives ● Purchase9 AFM
08,487 shares 0
Gewoon aandeel
AFM:165348 · 31 Oct 2024
Ideal exit: 28 Jul 2025 (T+270) Executives ● Purchase9 AFM
08,487 shares 0
Gewoon aandeel
AFM:165350 · 31 Oct 2024
Ideal exit: 28 Jul 2025 (T+270) Executives ● Purchase9 AFM
08,487 shares 0
Gewoon aandeel
AFM:165349 · 31 Oct 2024
Ideal exit: 28 Jul 2025 (T+270) Executives ● Purchase9 AFM
08,487 shares 0
Gewoon aandeel
AFM:161829 · 1 Aug 2024
Ideal exit: 28 Apr 2025 (T+270) Executives ● Purchase9 AFM
08,487 shares 0
Gewoon aandeel
AFM:161780 · 1 Aug 2024
Ideal exit: 28 Apr 2025 (T+270) Executives ● Purchase9 AFM
08,487 shares 0
Gewoon aandeel
AFM:161830 · 1 Aug 2024
Ideal exit: 28 Apr 2025 (T+270) Executives ● Purchase9 AFM
011,316 shares 0
Gewoon aandeel
AFM:161779 · 1 Aug 2024
Ideal exit: 28 Apr 2025 (T+270) Executives ● Purchase9 AFM
08,487 shares 0
Gewoon aandeel
AFM:161781 · 1 Aug 2024
Ideal exit: 28 Apr 2025 (T+270) Executives ● Purchase9 AFM
09,553 shares 0
Gewoon aandeel
AFM:159038 · 29 May 2024
Ideal exit: 23 Feb 2025 (T+270) Executives ● Purchase9 AFM
09,553 shares 0
Gewoon aandeel
AFM:159044 · 29 May 2024
Ideal exit: 23 Feb 2025 (T+270) Executives ● Purchase9 AFM
09,553 shares 0
Gewoon aandeel
AFM:159046 · 29 May 2024
Ideal exit: 23 Feb 2025 (T+270) Executives ● Purchase9 AFM
09,533 shares 0
Gewoon aandeel
AFM:159037 · 29 May 2024
Ideal exit: 23 Feb 2025 (T+270) 25 of 116 declarations
Load more (91 remaining) About Pharming Group N.V. Pharming Group N.V. is a biopharmaceutical company focused on developing treatments for rare diseases. It is listed on the Amsterdam Stock Exchange (XAMS).